Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nykode Therapeutics | Oslo | Salute | Ricerca medica e biotecnologica | 1,05 Mrd NOK | -1,9x | -0,34 | 3,03 NOK | -5,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arcticzymes Tech | Oslo | Salute | Ricerca medica e biotecnologica | 718,06 Mln NOK | 160,9x | -1,86 | 14,06 NOK | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,9% Rialzo | Fai l’upgrade a Pro+ | |
Thor Medical | Oslo | Salute | Ricerca medica e biotecnologica | 634,12 Mln NOK | -47,9x | 2,68 NOK | -1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Bergenbio | Oslo | Salute | Ricerca medica e biotecnologica | 354,91 Mln NOK | -1,9x | -0,03 | 9,10 NOK | -6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Lytix Biopharma AS | Oslo | Salute | Ricerca medica e biotecnologica | 295,68 Mln NOK | 5,88 NOK | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Lifecare | Oslo | Salute | Ricerca medica e biotecnologica | 199,73 Mln NOK | 0,46 | 12,75 NOK | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Exact Therapeutics AS | Oslo | Salute | Ricerca medica e biotecnologica | 116,77 Mln NOK | -3,5x | 0,06 | 3,78 NOK | 3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Ultimovacs | Oslo | Salute | Ricerca medica e biotecnologica | 84,64 Mln NOK | -0,6x | -0,02 | 2,44 NOK | -1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
PCI Biotech | Oslo | Salute | Ricerca medica e biotecnologica | 51,88 Mln NOK | -3,3x | -0,07 | 1,39 NOK | 1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Circio Holding | Oslo | Salute | Ricerca medica e biotecnologica | 38,20 Mln NOK | 0,6x | 0,03 | 0,73 NOK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
SoftOx Solutions | Oslo | Salute | Ricerca medica e biotecnologica | 25,37 Mln NOK | 0,010 NOK | 12,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |